From Hallelujah To Headwind: Pfizer's COVID-19 Franchise Hits The Downturn

 
• By Jessica Merrill

Pfizer expects Comirnaty and Paxlovid revenues to be drastically lower this year after pushing 2022 revenues over $100bn. Management said 2023 would be a transition year for the company.

downturn
Pfizer forecast a sharp decline in its COVID-19 revenues • Source: Shutterstock

More from COVID-19

More from Scrip